ID Week 2020: Updates in HIV

An infectious disease expert discusses the impact on HIV screening caused by the COVID-19 pandemic as well as the effects of HIV status on COVID-19 outcomes.

An expert physician reflects upon the notable adverse effect of weight gain seen in HIV care with integrase inhibitors and the implications of recent study results.

A key opinion leader reviews findings presented at ID Week 2020 from a post-hoc analysis of the AMBER study comparing GI tolerability of D/C/F/TAF to TDF.

An infectious disease expert discusses data on practical, physical, and psychological barriers to antiretroviral therapy adherence for patients with HIV.

Moti Ramgopal, MD, FACP, FIDSA, CPI, reviews data on high-dose versus standard-dose flu vaccines and additional findings in HIV care from ID Week 2020.